Jess Howell
Overview
Explore the profile of Jess Howell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eslam M, Fan J, Yu M, Wong V, Cua I, Liu C, et al.
Hepatol Int
. 2025 Feb;
PMID: 40016576
Metabolic dysfunction-associated fatty liver disease (MAFLD) affects over one-fourth of the global adult population and is the leading cause of liver disease worldwide. To address this, the Asian Pacific Association...
2.
Seaman C, Luong P, Xiao Y, Abeysuriya R, Howell J, Hellard M, et al.
Lancet Gastroenterol Hepatol
. 2023 Jul;
8(10):932-942.
PMID: 37517417
Hepatitis B is estimated to cause 500 000-900 000 deaths globally each year. WHO has targets for elimination by 2030; however, progress has stalled due to multiple barriers, notably a...
3.
Bell L, van Gemert C, Allard N, Brink A, Chan P, Cowie B, et al.
Lancet Reg Health West Pac
. 2023 Jul;
35:100740.
PMID: 37424691
Funding: Leila Bell was supported by an Australian Government Research Training Program (RTP) Scholarship, Australia. Funding sources had no role in paper design, data collection, data analysis, interpretation, or writing...
4.
Howell J, Majumdar A, Fink M, Byrne M, McCaughan G, Strasser S, et al.
Transplant Direct
. 2023 Apr;
8(8):e1345.
PMID: 37077731
Methods: This retrospective study included adult liver transplants between January 1' 1985' and December 31' 2019' from the Australian and New Zealand Liver and Intestinal Transplant Registry. Up to 4...
5.
Seaman C, Mvundura M, Frivold C, Morgan C, Jarrahian C, Howell J, et al.
PLOS Glob Public Health
. 2023 Mar;
2(5):e0000394.
PMID: 36962423
Timely birth dose vaccination is key for achieving elimination of hepatitis B, however, programmatic requirements for delivering current vaccine presentations to births outside of health facilities inhibits coverage within many...
6.
Moussa D, Wallace J, Manski-Nankervis J, Doyle J, Nguyen L, Boyle D, et al.
BMJ Open
. 2023 Mar;
13(3):e070663.
PMID: 36927591
Introduction: Despite the availability of effective, subsidised hepatitis B treatment, linkage to care and treatment rates remain very low globally. In Australia, specially trained primary care physicians (general practitioner, GPs)...
7.
Xiao Y, Hellard M, Thompson A, Seaman C, Howell J, Scott N
Med J Aust
. 2023 Jan;
218(4):168-173.
PMID: 36596568
Objectives: To assess the impact on diagnosis targets, cost, and cost-effectiveness of universal hepatitis B screening in Australia. Design: Markov model simulation of disease and care cascade progression for people...
8.
Sow A, Lemoine M, Toure P, Diop M, Lo G, De Veiga J, et al.
JHEP Rep
. 2022 Sep;
4(10):100533.
PMID: 36052221
Background & Aims: Strategies to implement HBV screening and treatment are critical to achieve HBV elimination but have been inadequately evaluated in sub-Saharan Africa (sSA). Methods: We assessed the feasibility...
9.
Preston S, Stutz M, Allison C, Nachbur U, Gouil Q, Tran B, et al.
Gastroenterology
. 2022 Aug;
163(6):1643-1657.e14.
PMID: 36037995
Background & Aims: Necroptosis is a highly inflammatory mode of cell death that has been implicated in causing hepatic injury including steatohepatitis/ nonalcoholic steatohepatitis (NASH); however, the evidence supporting these...
10.
Xiao Y, van Gemert C, Howell J, Wallace J, Richmond J, Adamson E, et al.
BMC Prim Care
. 2022 Jun;
23(1):137.
PMID: 35655159
Background: In Australia, only 22% of people with chronic hepatitis B (CHB) are clinically managed; and a national effort is engaging primary care workforce in providing CHB-related care. This study...